Filters
Children who were breastfed during the first 4–6 months of life are less likely to have central precocious puberty (CPP), with the protective association being partially mediated by prepubertal adiposity, according to a retrospective study.
Findings from the National Youth Mental Health Study demonstrate a high prevalence of severe depression and anxiety among youths in Singapore.
Juvenile idiopathic inflammatory myopathies (JIIM) negatively affect pubertal development and may even lead to growth failure, according to a study.
In the treatment of patients with developmental and epileptic encephalopathies (DEEs), the selective serotonin 5-HT2C receptor agonist bexicaserin is well tolerated and appears to reduce the frequency of countable motor seizures, according to a phase Ib/IIa study.
Breastfeeding provides several benefits to mothers and their children, including reduced risks in sudden infant death syndrome and allergic rhinitis, as well as improved physical fitness, reports a study.
Toddlers born to mothers with psychological distress through 1 year postpartum are more likely to have neurodevelopmental delay, according to a study.
Infants appear to have a more than fivefold greater odds of experiencing seizures in the presence of congenital heart disease (CHD), according to a study.
The fatty acid synthase inhibitor denifanstat shows potential for treating moderate-to-severe acne vulgaris, with good safety and tolerability, as demonstrated in a study from China presented at EADV 2025.
New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
New drug applications approved by US FDA as of 1-15 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.